CITY OF INDUSTRY, Calif., July 25 /PRNewswire-FirstCall/ -- U.S. BioDefense, Inc. announces that it has signed a Letter of Intent to Acquire Emergency Disaster Systems, Inc. (EDS), a forerunner in disaster preparedness.
EDS was originated in 1989 to provide earthquake preparedness supplies to communities through out California. The company began by providing individual preparedness kits that have evolved into Emergency Medical Services (EMS) support and mass casualty rapid response systems. Today the company serves communities, governments, industries and Fortune 500 companies around the world with innovative emergency preparedness technology.
“We are excited to inform our investors of our entry into the early disaster preparedness industry. Acquiring EDS and collaborating closely with their key personnel will allow us to make a quick and significant impact in the disaster preparedness and recovery industry,” said David Chin CEO of U.S. BioDefense.
Mr. Chin went on to say, “EDS will allow us to expand our Homeland Security division, by focusing on the mitigation, preparedness, response, and recovery from all forms of terrorist attacks and natural disasters.”
About U.S. BioDefense, Inc.
U.S. BioDefense is a Department of Defense central contractor that researches, develops, and commercializes homeland security and leading-edge biotechnology. U.S. BioDefense, Inc. is focused on transferring, researching, and commercializing groundbreaking technology from Universities, Research Labs, Fortune 500 Companies, and Government Agencies.
About Emergency Disaster Systems, Inc.
Emergency Disaster Systems is a leading provider of disaster mitigation services, emergency preparedness, and first response products to local communities, government agencies and Fortune 500 companies. Emergency Disaster Systems is committed to the protection of our children’s lives and communities from the devastating aftermath of a catastrophic event.
Contact: David Chin U.S. BioDefense, Inc. 626-961-0562
U.S. BioDefense, Inc.
CONTACT: David Chin of U.S. BioDefense, Inc., +1-626-961-0562
